| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $921,539 ) |
| | 2025 | 2025 | ALLERDIA INC | 2010 MALCOLM AVE | LOS ANGELES | CA | 90025-6304 | LOS ANGELES | USA | R44HL167289 | Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE | 000 | 3 | NIH | 7/24/2025 | $921,539 |
| | 2025 | 2023 | ALLERDIA INC | 2010 MALCOLM AVE | LOS ANGELES | CA | 90025-6304 | LOS ANGELES | USA | R43HL167289 | Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE | 000 | 1 | NIH | 4/2/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,109,675 ) |
| | 2024 | 2024 | ALLERDIA INC | 2010 MALCOLM AVE | LOS ANGELES | CA | 90025-6304 | LOS ANGELES | USA | R44HL167289 | Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE | 000 | 2 | NIH | 7/10/2024 | $1,109,675 |
| | 2024 | 2023 | ALLERDIA INC | 2010 MALCOLM AVE | LOS ANGELES | CA | 90025-6304 | LOS ANGELES | USA | R43HL167289 | Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE | 000 | 1 | NIH | 7/18/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $331,305 ) |
| | 2023 | 2023 | ALLERDIA INC | 2010 MALCOLM AVE | LOS ANGELES | CA | 90025-6304 | LOS ANGELES | USA | R43HL167289 | Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE | 000 | 1 | NIH | 1/16/2023 | $275,740 |
| | 2023 | 2023 | ALLERDIA INC | 2010 MALCOLM AVE | LOS ANGELES | CA | 90025-6304 | LOS ANGELES | USA | R43HL167289 | Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE | 001 | 1 | NIH | 9/18/2023 | $55,565 |
|
|
